The expression of ANXA2 in breast invasive carcinoma (BRCA), KICH, lung adenocarcinoma (LUAD) and PRAD was lower compared with corresponding normal tissues (Figure 1A). This evidence concerns the gene ANXA2 and prostate adenocarcinoma.